HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 10, October 2021 – An Inquiry into Life in the Universe       » A New Cell Factory for High-Purity DHA Production       » A New Nanoplatform With Dual-Mode Therapeutic Pathways       » Improving Breast Cancer Detection With New Liquid Biopsy Diagnosis Model       » Alginic Acid: The Secret to Building Better Bones       » Next Generation Genome Engineering With Mini CRISPR — Made Smaller to Deliver Better      
Vol 25, No. 10, October 2021   |   Issue PDF view/purchase
INSIDE INDUSTRY
Improving Patient Diagnoses With Healthcare AI?
TIBCO and National University Health System collaborate to enhance data analytics and integrate patient data.

TIBCO Software Inc., a global leader in enterprise data, empowers its customers to connect, unify, and confidently predict business outcomes, solving the world’s most complex data-driven challenges. In September, TIBCO announced a collaboration with National University Health System (NUHS) to enhance the future of healthcare through the use of data analytics and artificial intelligence (AI) on NUHS' ENDEAVOUR AI platform. Implementations of the technology range from shortening hospital patients’ length of stay to helping identify breast cancer.

NUHS employs TIBCO technology, including TIBCO BusinessWorks™, TIBCO® Streaming, TIBCO® Messaging, and TIBCO Spotfire®, in its ENDEAVOUR AI platform to support the integration of real-time medical data from Electronic Medical Record (EMR) systems. With this platform, multiple complex AI tools integrate to provide aggregated predictions and visualisation of insights, enhancing patient care and services.

"We leverage the capabilities of AI to improve healthcare practices and outcomes, enabling clinical practitioners to make faster, more accurate diagnoses and precise treatments," said Associate Professor Ngiam Kee Yuan, group chief technology officer, NUHS. "Healthcare institutions aggregate vast quantities of data, but most of the data collected is only analysed retrospectively. TIBCO technology enables the NUHS ENDEAVOUR AI platform to stream data in real-time, feeding live data into AI models that produce actionable insights on the fly.”

NUHS plans to deploy as many as 150 distinct AI and automation tools as microservices on ENDEAVOUR AI. These AI tools incorporate multi-domain patient information, such as demographics, text, images, lab data, and medications prescribed to provide a synthesis of a patient's condition. This translates into significant cost savings, from a patient’s care at admission to predicting a patient’s length of stay, therefore optimising scarce bed resources.

Among other projects, the NUHS platform improves breast cancer detection rates, predicting the risk of breast cancer in women admitted to the hospital, regardless of the reason for admission. The AI tool instantly identifies risk factors for breast cancer and, if needed, the patients concerned are referred for a mammogram and specialist treatment.

“Healthcare’s digital future looks promising as patients become more comfortable using digital services for complex and sensitive issues. The collaboration with NUHS leverages our respective strengths in data, analytics, and network connectivity to help organisations navigate the complex transition to a value-based healthcare system,” said Erich Gerber, senior vice president, APJ and EMEA, TIBCO. “We see TIBCO’s work with NUHS as essential to sharing our expertise and industry know-how so technology can continue to make a positive impact on peoples’ lives.”


Source: TIBCO Software Inc.

FORTHCOMING ISSUE  
Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific
NEWS CRUNCH  
news Asia Summit on Global Health (ASGH) 2021 — Shaping a Resilient and Sustainable Future
news TechInnovation 2021 Virtual Exhibition to Showcase Sustainable Energy, Food, and Healthcare Solutions
news A New Approach for Effective Gout Treatment
news TechInnovation Returns from 28 to 30 September 2021
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy